Get the Stockscreener App
7.52
3.22%
-0.25
After Hours:
7.50
-0.02
-0.27%
Lifecore Biomedical Inc stock is traded at $7.52, with a volume of 135.10K.
It is down -3.22% in the last 24 hours and down -1.44% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$7.77
Open:
$7.77
24h Volume:
135.10K
Relative Volume:
0.87
Market Cap:
$281.31M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
150.40
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
-0.13%
1M Performance:
-1.44%
6M Performance:
+16.95%
1Y Performance:
+46.87%
1-Day Range:
$7.4151
$7.77
1-Week Range:
$7.00
$7.82
52-Week Range:
$4.33
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.52 | 262.23M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Is now a turning point for Lifecore Biomedical Inc.July 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Applying Elliott Wave Theory to Lifecore Biomedical Inc.Portfolio Profit Report & High Yield Equity Trading Tips - Newser
Can trapped investors hope for a rebound in Lifecore Biomedical Inc.Market Activity Recap & Long-Term Growth Portfolio Plans - Newser
What to do if you’re stuck in Lifecore Biomedical Inc.2025 Short Interest & Real-Time Volume Spike Alerts - Newser
What institutional flow reveals about Lifecore Biomedical Inc.Inflation Watch & Risk Adjusted Swing Trade Ideas - Newser
Is Lifecore Biomedical Inc. stock reversal real or fakeJuly 2025 Macro Moves & Daily Growth Stock Tips - Newser
How to monitor Lifecore Biomedical Inc. with trend dashboardsJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - Newser
Will Lifecore Biomedical Inc. stock recover after recent dropWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser
Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Price action breakdown for Lifecore Biomedical Inc.July 2025 Rallies & Real-Time Volume Spike Alerts - Newser
Building trade automation scripts for Lifecore Biomedical Inc.Portfolio Profit Report & Precise Trade Entry Recommendations - Newser
What earnings revisions data tells us about Lifecore Biomedical Inc.2025 Top Gainers & Reliable Volume Spike Trade Alerts - Newser
Identifying reversal signals in Lifecore Biomedical Inc.July 2025 Chart Watch & Free Technical Pattern Based Buy Signals - Newser
Is Lifecore Biomedical Inc. stock entering bullish territoryWeekly Profit Report & Growth Focused Entry Reports - Newser
What’s next for Lifecore Biomedical Inc. stock priceWeekly Risk Summary & Smart Allocation Stock Reports - Newser
Using portfolio simulators with Lifecore Biomedical Inc. included2025 Institutional Moves & Weekly Chart Analysis and Guides - Newser
Should you wait for a breakout in Lifecore Biomedical Inc.Weekly Trade Recap & Stepwise Entry and Exit Trade Signals - Newser
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Relative strength of Lifecore Biomedical Inc. in sector analysisJuly 2025 Chart Watch & Risk Adjusted Buy and Sell Alerts - Newser
Analyzing Lifecore Biomedical Inc. with multi timeframe chartsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Regression analysis insights on Lifecore Biomedical Inc. performanceBull Run & Verified Technical Signals - Newser
Published on: 2025-09-10 03:47:41 - Newser
Evaluating Lifecore Biomedical Inc. with trendline analysisQuarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
What is KeyCorp's Estimate for LFCR Q1 Earnings? - MarketBeat
Tools to assess Lifecore Biomedical Inc.’s risk profile2025 Momentum Check & Low Drawdown Trading Strategies - Newser
Live market analysis of Lifecore Biomedical Inc.Buy Signal & Verified Short-Term Plans - Newser
Technical analysis overview for Lifecore Biomedical Inc. stockInsider Buying & Comprehensive Market Scan Insights - Newser
Lifecore granted Sector Weight rating at KeyBanc on growth trajectory - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
What to expect from Lifecore Biomedical Inc. in the next 30 daysBull Run & Technical Pattern Recognition Alerts - Newser
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):